Newsroom

Newsroom

Press Releases

1 of 1

Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
July 29, 2026
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
June 14, 2026
Waldencast Announces Sale of Obagi Medical to Bridgepoint
May 31, 2026
Waldencast announces conclusion of SEC investigation
April 27, 2026
Waldencast Reports Q4 2025 and FY 2025 Financial Results
March 12, 2026
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™
January 21, 2026